2014•Unpublished venueRequires access

Clinical curative effect of Huangkui capsule in treating early stage diabetic nephropathy and influence on patients with hyperlipidemia

LI Zhao-yon

Open publisher page 1 citations

Abstract

Objective To explore the effect of huangkui capsule in early and middle stage of diabetic nephropathy patients and the influence for blood lipid.Methods:126 cases with early and middle stage of diabetic nephropathy were randomly divided into control group and experience group.Control group were given routine treatment,and experience group received huangkui capsule therapy.Results The effective rate of treatment in experience group was much higher than that in control group(P 0.05);SCr,BUN,U-β2MG,urinary albumin excretion rate,the total 24 hour urine protein,TG,TC and LDL-C after treatment in experience group were much lower than those in control group(P 0.05);Doppler results showed that Vs and Vd after treatment in experience group were superior to control group(P 0.05).Conclusions Huangkui capsule for early and middle stage of diabetic nephropathy patients greatly improve renal function and renal blood flow,decrease the blood lipid and delay the disease progression.

About this research paper

What this paper is about

Objective To explore the effect of huangkui capsule in early and middle stage of diabetic nephropathy patients and the influence for blood lipid.Methods:126 cases with early and middle stage of diabetic nephropathy were randomly divided into control group and experience group.Control group were given routine treatment,and experience group received huangkui capsule therapy.Results The effective rate of treatment in experience group was much higher than that in control group(P 0.05);SCr,BUN,U-β2MG,urinary albumin excretion rate,the total 24 hour urine protein,TG,TC and LDL-C after treatment in experience group were much lower than those in control group(P 0.05);Doppler results showed that Vs and Vd after treatment in experience group were superior to control group(P 0.05).Conclusions Huangkui capsule for early and middle stage of diabetic nephropathy patients greatly improve renal function and renal blood flow,decrease the blood lipid and delay the disease progression.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the effect of huangkui capsule in early and middle stage of diabetic nephropathy patients and the influence for blood lipid.Methods:126 cases with early and middle stage of diabetic nephropathy were randomly divided into control group and experience group.Control group were given routine treatment,and experience group received huangkui capsule therapy.Results The effective rate of treatment in experience group was much higher than that in control group(P 0.05);SCr,BUN,U-β2MG,urinary albumin excretion rate,the total 24 hour urine protein,TG,TC and LDL-C after treatment in experience group were much lower than those in control group(P 0.05);Doppler results showed that Vs and Vd after treatment in experience group were superior to control group(P 0.05).Conclusions Huangkui capsule for early and middle stage of diabetic nephropathy patients greatly improve renal function and renal blood flow,decrease the blood lipid and delay the disease progression.

Key concepts: Medicine, Diabetic nephropathy, Capsule, Hyperlipidemia, Blood lipids, Renal function, Internal medicine, Urology

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical curative effect of Huangkui capsule in treating early stage diabetic nephropathy and influence on patients with hyperlipidemia — Research Paper | ScholarLens